
Examine new cell-model research suggesting protein aggregates may initially shield neurons and prompt reevaluation of aggregate-targeted therapeutic approaches.
Key Takeaways
- CRISPR editing reduced CAG repeats and enabled fluorescent tracking of mutant proteins
- Inclusion bodies in patient-derived cell models increased neuronal survival after chemical stress
- Deleting ATF3 eliminated inclusion body formation and increased neuronal vulnerability
